Source:http://linkedlifedata.com/resource/pubmed/id/21386735
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-4-6
|
pubmed:abstractText |
Increased expression of sodium iodide symporter (NIS) is required for reporter gene imaging and effective radioiodine treatment of tumor. As the early-growth response-1 (Egr1) promoter is activated by radioisotopes, the existence of a positive feedback effect of I-promoted Egr1-hNIS expression is possible. Compared with a widely used cytomegalovirus (CMV) promoter, we investigated a possible increased activity of I-stimulated human NIS (hNIS) transgene expression in malignant glioma using a baculovirus vector containing the Egr1 promoter.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1473-5628
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
402-9
|
pubmed:meshHeading |
pubmed-meshheading:21386735-Baculoviridae,
pubmed-meshheading:21386735-Cell Line, Tumor,
pubmed-meshheading:21386735-Cytomegalovirus,
pubmed-meshheading:21386735-Early Growth Response Protein 1,
pubmed-meshheading:21386735-Feasibility Studies,
pubmed-meshheading:21386735-Feedback,
pubmed-meshheading:21386735-Gene Therapy,
pubmed-meshheading:21386735-Genetic Vectors,
pubmed-meshheading:21386735-Glioma,
pubmed-meshheading:21386735-Humans,
pubmed-meshheading:21386735-Immunohistochemistry,
pubmed-meshheading:21386735-Iodine Radioisotopes,
pubmed-meshheading:21386735-Promoter Regions, Genetic,
pubmed-meshheading:21386735-Symporters,
pubmed-meshheading:21386735-Transfection,
pubmed-meshheading:21386735-Transgenes
|
pubmed:year |
2011
|
pubmed:articleTitle |
Feasibility of a novel positive feedback effect of 131I-promoted Bac-Egr1-hNIS expression in malignant glioma through baculovirus: a comparative study with Bac-CMV-hNIS.
|
pubmed:affiliation |
Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|